Capricor Therapeutics reported $4.31M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Bluebird Bio BLUE:US $ 239.63M 8.68M
Capricor Therapeutics CAPR:US $ 4.31M 654.54K
Cytokinetics CYTK:US $ 74.64M 17M
Cytori Therapeutics CYTX:US $ 3.5M 924K
Geron GERN:US $ 25.78M 3.21M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Newlink Genetics NLNK:US 7.5M 1.18M
Prothena PRTA:US 29.95M 2.17M
Ptc Therapeutics PTCT:US $ 231.82M 16.65M
Sarepta Therapeutics SRPT:US $ 228.35M 103.31M
Vascular Biogenics VBLT:US 6.71M 1.5M